Literature DB >> 19095998

Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration.

Hiroyuki Suzuki1, Keita Kimura, Heigoro Shirai, Kunie Eguchi, Sadaharu Higuchi, Akinari Hinoki, Kazuhiro Ishimaru, Eugen Brailoiu, Danny N Dhanasekaran, Laura N Stemmle, Timothy A Fields, Gerald D Frank, Michael V Autieri, Satoru Eguchi.   

Abstract

BACKGROUND: Although, endothelial nitric oxide (NO) synthase (eNOS) is believed to antagonize vascular remodeling induced by the angiotensin II (AngII) type-1 receptor, the exact signaling mechanism remains unclear. METHODS AND
RESULTS: By expressing eNOS to vascular smooth muscle cells (VSMCs) via adenovirus, we investigated a signal transduction mechanism of the eNOS gene transfer in preventing vascular remodeling induced by AngII. We found marked inhibition of AngII-induced Rho/Rho-kinase activation and subsequent VSMC migration by eNOS gene transfer whereas G(q)-dependent transactivation of the epidermal growth factor receptor by AngII remains intact. This could be explained by the specific inhibition of G(12/13) activation by eNOS-mediated G(12/13) phosphorylation.
CONCLUSIONS: The eNOS/NO cascade specifically targets the Rho/Rho-kinase system via inhibition of G(12/13) to prevent vascular migration induced by AngII, representing a novel signal cross-talk in cardiovascular protection by NO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095998      PMCID: PMC2704976          DOI: 10.1161/ATVBAHA.108.181024

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  57 in total

Review 1.  Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression.

Authors:  T M Lincoln; N Dey; H Sellak
Journal:  J Appl Physiol (1985)       Date:  2001-09

2.  Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion.

Authors:  Ramona S Scotland; Manuel Morales-Ruiz; Yan Chen; Jun Yu; Radu Daniel Rudic; David Fulton; Jean-Philippe Gratton; William C Sessa
Journal:  Circ Res       Date:  2002-05-03       Impact factor: 17.367

3.  Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation.

Authors:  Fiona M D'Souza; Rodney L Sparks; Huiying Chen; Philip J Kadowitz; James R Jeter
Journal:  Am J Physiol Cell Physiol       Date:  2002-09-18       Impact factor: 4.249

4.  Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons.

Authors:  Catalin M Filipeanu; Eugen Brailoiu; Siok Le Dun; Nae J Dun
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

5.  Galpha(12) and Galpha(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity.

Authors:  Yoshiaki Yamaguchi; Hironori Katoh; Kazutoshi Mori; Manabu Negishi
Journal:  Curr Biol       Date:  2002-08-06       Impact factor: 10.834

6.  cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions.

Authors:  Tanima Gudi; Jeffrey C Chen; Darren E Casteel; Tammy M Seasholtz; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2002-07-15       Impact factor: 5.157

7.  Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide.

Authors:  Rien van Haperen; Monique de Waard; Elza van Deel; Barend Mees; Michael Kutryk; Thijs van Aken; Jaap Hamming; Frank Grosveld; Dirk J Duncker; Rini de Crom
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

8.  Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation.

Authors:  Jeanne M Manganello; Jin-Sheng Huang; Tohru Kozasa; Tatyana A Voyno-Yasenetskaya; Guy C Le Breton
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

Review 9.  Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.

Authors:  Chen Yan; Dongsoo Kim; Toru Aizawa; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

10.  Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II.

Authors:  Sui Zhang; Yu Yang; Bruce C Kone; Julius C Allen; Andrew M Kahn
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  20 in total

Review 1.  Deconstructing aqueous humor outflow - The last 50 years.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2020-06-23       Impact factor: 3.467

2.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells".

Authors:  Keita Kimura; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-09       Impact factor: 4.249

4.  Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.

Authors:  Akira Takaguri; Heigoro Shirai; Keita Kimura; Akinari Hinoki; Kunie Eguchi; MaryEllen Carlile-Klusacek; Baohua Yang; Victor Rizzo; Satoru Eguchi
Journal:  J Mol Cell Cardiol       Date:  2010-12-21       Impact factor: 5.000

Review 5.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

6.  Bimodal effect of oxidative stress in internal anal sphincter smooth muscle.

Authors:  Jagmohan Singh; Sumit Kumar; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

Review 7.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

8.  Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.

Authors:  Takehiko Takayanagi; Kevin J Crawford; Tomonori Kobayashi; Takashi Obama; Toshiyuki Tsuji; Katherine J Elliott; Tomoki Hashimoto; Victor Rizzo; Satoru Eguchi
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

9.  p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo.

Authors:  Akinari Hinoki; Keita Kimura; Sadaharu Higuchi; Kunie Eguchi; Akira Takaguri; Kazuhiro Ishimaru; Gerald D Frank; William T Gerthoffer; Laura J Sommerville; Michael V Autieri; Satoru Eguchi
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

Review 10.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.